Ahmed Bennis/X
Aug 30, 2026, 16:06
Ahmed Bennis: Highly Individualized Anticoagulation Decision-Making Stratified by eGFR
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X:
“ESC Congress 2026 Munich.
Highly individualized decision-making, stratified by eGFR:
- eGFR 30–59: DOAC preferred over LMWH or VKA (Class I) for both VTE and AF.
- eGFR 15–29: Factor Xa inhibitor preferred over VKA (Class IIa/IIb).
- Dialysis or eGFR below 15: VKA or low-dose apixaban (Class IIb).”
Other posts featuring Ahmed Bennis on Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question